AdAlta Investor Relations Material
Latest events
Study Update
AdAlta
H2 2025
26 Aug, 2025
Investor Presentation
18 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AdAlta Limited
Access all reports
AdAlta Limited is an Australian biotechnology company focused on the discovery and development of novel protein-based therapeutics. The company utilizes its proprietary i-body technology platform to create next-generation biologic drugs targeting a range of diseases, including fibrosis and immune-related conditions. AdAlta Limited is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for AdAlta Limited
Investor Presentation
AdAlta Limited
Investor Update
AdAlta Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
1AD
Country
🇦🇺 Australia